Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial)

BACKGROUND: Severe hypoglycaemia (SH) is one of the most feared complications of type 1 diabetes (T1DM) with a reported prevalence of nearly 40%. In randomized trials of Multiple Daily Injections (MDI) and Continuous Subcutaneous Insulin Infusion (CSII) therapy there is a possible benefit of CSII in...

Descripción completa

Detalles Bibliográficos
Autores principales: Little, Stuart, Chadwick, Thomas, Choudhary, Pratik, Brennand, Cath, Stickland, Julia, Barendse, Shalleen, Olateju, Tolulope, Leelarathna, Lalantha, Walkinshaw, Emma, Tan, Horng K, Marshall, Sally M, Thomas, Reena M, Heller, Simon, Evans, Mark, Kerr, David, Flanagan, Daniel, Speight, Jane, Shaw, James AM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556156/
https://www.ncbi.nlm.nih.gov/pubmed/23237320
http://dx.doi.org/10.1186/1472-6823-12-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556156/
https://www.ncbi.nlm.nih.gov/pubmed/23237320
http://dx.doi.org/10.1186/1472-6823-12-33

Ejemplares similares